-
Mashup Score: 0
The purpose of the study was to develop care and professional education competencies that address prediabetes, diabetes, and cardiometabolic conditions at the individual and population levels and to promote self-assessment and professional development goals related to the knowledge, skills, and abilities required to effectively work with PWD and related conditions. There are 130 million Americans currently living with, affected by, or at risk for diabetes. As a result, clinicians, nonclinical providers,
Source: journals.sagepub.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 21Study reveals genetic clusters and biological pathways that may explain differences in type 2 diabetes risk - 2 month(s) ago
The development and progression of type 2 diabetes are affected by numerous biological processes, such as the body’s response to insulin, the health of insulin-producing pancreatic beta cells, and the …
Source: medicalxpress.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Maternal Study Satisfaction Increases Visit Compliance in Children at Risk for Diabetes - 2 month(s) ago
Maternal characteristics, sociodemographic factors, and paternal participation during the initial year of the TEDDY study were identified as key predictors of enhanced visit compliance in a pediatric cohort genetically predisposed to type 1 diabetes.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 10FLOW: Semaglutide slows CKD progression, cuts risks for kidney, CV death in diabetes - 2 month(s) ago
Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.The FLOW trial enrolled 3,533 people with type 2 diabetes and CKD. Participants were randomly assigned to receive either once-weekly semaglutide 1 mg (Ozempic, Novo
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1
Cutting-edge advancements in endocrinology continue to move diabetes treatment in the right direction faster than ever before. The treatment of diabetes is continually evolving. More than a century ago, a diabetes diagnosis was a death sentence, and although there is not yet a cure, endless updates in diabetes care help ease the burden of both…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 18Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands - 2 month(s) ago
Real-world data obtained in this trial demonstrate that use of the bihormonal FCL system was associated with good glycaemic control in patients who completed 1 year of treatment, and could help relieve these individuals with type 1 diabetes from making treatment decisions and the burden of carbohydrate counting.
Source: www.thelancet.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6Q&A: Patient-centered focus should be core of diabetes management - 2 month(s) ago
Making people with diabetes the center of all aspects of diabetes management is the focus of a new position statement published by the Endocrine Society. On Feb. 21, the Endocrine Society released a position statement in The Journal of Clinical Endocrinology & Metabolism that discussed the importance of making patient experiences an integral part of diabetes management. The position statement
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6Q&A: Patient-centered focus should be core of diabetes management - 2 month(s) ago
Making people with diabetes the center of all aspects of diabetes management is the focus of a new position statement published by the Endocrine Society. On Feb. 21, the Endocrine Society released a position statement in The Journal of Clinical Endocrinology & Metabolism that discussed the importance of making patient experiences an integral part of diabetes management. The position statement
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 27
Research targeting the insulin-inhibitory receptor, or inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy.
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Diabetes and Your Feet - 2 month(s) ago
Find out about daily care to prevent foot complications.
Source: www.cdc.govCategories: General Medicine News, EndocrinologyTweet
Checkout this research article from @ADCESdiabetes, "Identifying Competencies for Diabetes Community Care Coordinators". Learn about strategies to enhance patient outcomes for individuals with #Diabetes and related conditions. https://t.co/Z9OkTugXr9